Glucose, High Blood Clinical Trial
Official title:
Hydration to Optimize Metabolism
This study evaluates hydration (1.5 L of water daily during 1 year) in the lowering of blood glucose concentration in adults with signs of dehydration (elevated levels of the vasopressin marker copeptin and high urine osmolality). Half of participants will in addition to lifestyle advice receive extra water on top of their habitual fluid intake, and the other half (control) will receive only lifestyle advice.
High plasma concentration of vasopressin (i.e. antidiuretic hormone) is a novel and independent risk factor for type 2 diabetes, the metabolic syndrome, cardiovascular disease and premature death. The main physiological role of vasopressin is to maintain constant plasma osmolality. Previous studies in rats and mendelian randomization studies in humans suggest causality between elevated vasopressin concentration and elevated plasma glucose concentration. As vasopressin can be suppressed by increasing water intake, we hypothesize that water supplementation in individuals with high vasopressin can lower plasma glucose and prevent diabetes. The aim of this project is to test in a single-centre randomized clinical trial (RCT), if water supplementation in subjects with high plasma levels of vasopressin (measured by a stable vasopressin marker of its precursor hormone called copeptin) can reduce fasting levels of glucose (primary outcome measure), risk of new-onset diabetes and other cardiometabolic risk factors (secondary outcome measures). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04230694 -
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
|
N/A | |
Active, not recruiting |
NCT04641689 -
Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment
|
N/A | |
Active, not recruiting |
NCT05056376 -
Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs
|
N/A | |
Completed |
NCT04547023 -
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy
|
N/A | |
Completed |
NCT04648397 -
The Effect of Chewing Duration on Blood Glucose Levels
|
N/A | |
Enrolling by invitation |
NCT04846751 -
Exercise Type That Faster Reduces Postprandial Glycemia.
|
N/A | |
Active, not recruiting |
NCT04893148 -
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
|
Phase 4 | |
Active, not recruiting |
NCT01028846 -
Central Mechanisms That Regulate Glucose Metabolism in Humans
|
Phase 4 | |
Completed |
NCT03252704 -
Post-prandial Glycemic Response to Fiber in Healthy Adults
|
N/A | |
Completed |
NCT05215210 -
The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels
|
N/A | |
Completed |
NCT03972878 -
Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products
|
N/A | |
Completed |
NCT05071950 -
The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting
|
N/A | |
Suspended |
NCT03428295 -
Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC
|
Phase 1/Phase 2 | |
Suspended |
NCT03566511 -
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
|
Phase 2 | |
Completed |
NCT04483453 -
Effect of Nutritional Intervention on Metabolic Response in Infants
|
N/A | |
Completed |
NCT03344185 -
The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day
|
N/A | |
Completed |
NCT03544411 -
Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM
|
Phase 1 | |
Completed |
NCT05182190 -
Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults
|
N/A | |
Completed |
NCT04438018 -
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
|
||
Completed |
NCT03811132 -
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)
|